Drug recall · September 26, 2018
Morphine Sulfate Extended-Release Tablets recall
Why: Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01
- Lots / codes
Lot# S800232, Exp 2/20
- Quantity
- 4716 bottle
- Company
- Lupin Somerset, Somerset, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- August 23, 2018 · Voluntary: Firm initiated
- Classified
- September 27, 2018
- Reported
- September 26, 2018
- Ended
- October 14, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.